Resolving the Paradox of Colon Cancer Through the Integration of Genetics, Immunology, and the Microbiota.


Journal

Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960

Informations de publication

Date de publication:
2020
Historique:
received: 31 08 2020
accepted: 09 11 2020
entrez: 31 12 2020
pubmed: 1 1 2021
medline: 22 6 2021
Statut: epublish

Résumé

While colorectal cancers (CRC) are paradigmatic tumors invaded by effector memory lymphocytes, the mechanisms accounting for the relative resistance of MSI negative CRC to immunogenic cell death mediated by oxaliplatin and immune checkpoint inhibitors has remained an open conundrum. Here, we propose the viewpoint where its microenvironmental contexture could be explained -at least in part- by macroenvironmental cues constituted by the complex interplay between the epithelial barrier, its microbial ecosystem, and the local immune system. Taken together this dynamic ménage-à-trois offers novel coordinated actors of the humoral and cellular immune responses actionable to restore sensitivity to immune checkpoint inhibition. Solving this paradox involves breaking tolerance to crypt stem cells by inducing the immunogenic apoptosis of ileal cells in the context of an ileal microbiome shifted towards immunogenic bacteria using cytotoxicants. This manoeuver results in the elicitation of a productive Tfh and B cell dialogue in mesenteric lymph nodes culminating in tumor-specific memory CD8

Identifiants

pubmed: 33381121
doi: 10.3389/fimmu.2020.600886
pmc: PMC7768083
doi:

Substances chimiques

Antineoplastic Agents 0
Biomarkers, Tumor 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

600886

Informations de copyright

Copyright © 2020 Fidelle, Yonekura, Picard, Cogdill, Hollebecque, Roberti and Zitvogel.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

PLoS One. 2013;8(2):e57114
pubmed: 23437326
Nat Commun. 2015 Mar 11;6:6528
pubmed: 25758642
Exp Biol Med (Maywood). 2004 Jul;229(7):586-97
pubmed: 15229352
PLoS Genet. 2008 Nov;4(11):e1000255
pubmed: 19023400
Nat Commun. 2020 May 25;11(1):2608
pubmed: 32451418
Curr Oncol Rep. 2001 Mar;3(2):147-55
pubmed: 11177747
Nat Immunol. 2020 Mar;21(3):343-353
pubmed: 32066951
Nat Med. 2014 Nov;20(11):1301-9
pubmed: 25344738
Ann Surg Oncol. 2018 Aug;25(8):2323-2331
pubmed: 29770915
Gastroenterology. 2010 Jun;138(6):2029-2043.e10
pubmed: 20420944
Front Oncol. 2019 Nov 08;9:1102
pubmed: 31781481
Oncoimmunology. 2015 Jun 5;4(7):e1058597
pubmed: 26140250
Cell. 2015 Oct 8;163(2):367-80
pubmed: 26411289
N Engl J Med. 2016 Nov 10;375(19):1856-1867
pubmed: 27718784
J Immunol. 2011 Jul 15;187(2):733-47
pubmed: 21666057
Front Immunol. 2017 Dec 22;8:1900
pubmed: 29375559
Nat Rev Cancer. 2006 Oct;6(10):789-802
pubmed: 16990856
Microb Cell. 2016 Feb 23;3(3):101-108
pubmed: 28357340
Science. 2015 Nov 20;350(6263):972-8
pubmed: 26516201
Cell. 2019 Aug 8;178(4):795-806.e12
pubmed: 31398337
Cancer Res. 2015 Sep 15;75(18):3812-22
pubmed: 26208907
Cell Mol Gastroenterol Hepatol. 2020;9(1):33-45
pubmed: 31344510
Recent Pat Anticancer Drug Discov. 2012 Sep;7(3):265-96
pubmed: 22630596
Cell Host Microbe. 2013 Aug 14;14(2):195-206
pubmed: 23954158
Front Cell Infect Microbiol. 2020 Apr 09;10:151
pubmed: 32328469
Cancer Cell. 2016 Jul 11;30(1):147-160
pubmed: 27411589
Front Immunol. 2019 Dec 17;10:2936
pubmed: 31921188
Biomed Res Int. 2020 May 14;2020:5294043
pubmed: 32509862
Nat Commun. 2019 Sep 13;10(1):4186
pubmed: 31519915
Nature. 2017 Nov 16;551(7680):340-345
pubmed: 29144460
Clin Cancer Res. 2018 Dec 15;24(24):6125-6135
pubmed: 30049748
Nat Med. 2019 Apr;25(4):679-689
pubmed: 30936547
J Transl Med. 2015 Mar 28;13:101
pubmed: 25889931
Ann Oncol. 2019 Jul 1;30(7):1096-1103
pubmed: 31038663
Nat Med. 2015 Nov;21(11):1350-6
pubmed: 26457759
J Infect Dis. 2011 Feb 1;203(3):306-11
pubmed: 21208921
Toxicol In Vitro. 2006 Mar;20(2):163-75
pubmed: 16271446
Gastroenterology. 2017 Dec;153(6):1621-1633.e6
pubmed: 28823860
Cancer Cell. 2018 Dec 10;34(6):1012-1026.e3
pubmed: 30537506
Sci Transl Med. 2016 Feb 24;8(327):327ra26
pubmed: 26912905
Nat Med. 2019 Apr;25(4):667-678
pubmed: 30936548
Lancet. 2018 May 26;391(10135):2128-2139
pubmed: 29754777
Science. 2019 May 3;364(6439):485-491
pubmed: 31048490
Cancer Cell. 2009 Aug 4;16(2):91-102
pubmed: 19647220
Science. 2006 Sep 29;313(5795):1960-4
pubmed: 17008531
Proc Natl Acad Sci U S A. 2012 Feb 7;109(6):2108-13
pubmed: 22308390
Gut. 2014 Dec;63(12):1932-42
pubmed: 24658599
Genomics Proteomics Bioinformatics. 2018 Feb;16(1):73-84
pubmed: 29505855
DNA Cell Biol. 2017 Sep;36(9):794-800
pubmed: 28650673
Gut. 2017 Nov;66(11):1983-1994
pubmed: 28153960
BMC Cancer. 2019 Oct 17;19(1):964
pubmed: 31623592
Science. 2012 Sep 28;337(6102):1678-84
pubmed: 23019653
Nat Immunol. 2019 Mar;20(3):326-336
pubmed: 30778252
Cell. 2019 Nov 14;179(5):1191-1206.e21
pubmed: 31730857
Microbes Environ. 2017 Dec 27;32(4):300-313
pubmed: 29129876
Lancet. 2019 Oct 19;394(10207):1467-1480
pubmed: 31631858
Gastroenterology. 2014 May;146(6):1449-58
pubmed: 24486050
Nat Rev Cancer. 2017 Aug;17(8):457-474
pubmed: 28706266
Nat Rev Clin Oncol. 2018 Jun;15(6):382-396
pubmed: 29636538
Ann Oncol. 2018 Jun 1;29(6):1437-1444
pubmed: 29617710
Genome Res. 2012 Feb;22(2):299-306
pubmed: 22009989
Nat Rev Microbiol. 2016 Jan;14(1):20-32
pubmed: 26499895
Nature. 2020 Jan;577(7791):549-555
pubmed: 31942075
Lancet Oncol. 2020 Oct;21(10):1353-1365
pubmed: 32919526
Genes Dev. 2007 Oct 15;21(20):2525-38
pubmed: 17938238
N Engl J Med. 2015 Jun 25;372(26):2509-20
pubmed: 26028255
Int Immunopharmacol. 2017 Aug;49:95-101
pubmed: 28558303
J Gastrointest Cancer. 2012 Sep;43(3):444-55
pubmed: 21989899
Nature. 2020 Jan;577(7791):556-560
pubmed: 31942077
Nat Commun. 2020 Jul 30;11(1):3801
pubmed: 32732879
Oncoimmunology. 2019 Feb 18;8(4):e1568812
pubmed: 30906663
Cell. 2018 Nov 15;175(5):1307-1320.e22
pubmed: 30392957
Nature. 2008 Nov 27;456(7221):507-10
pubmed: 18987631
Ann Surg Oncol. 2018 Jun;25(6):1454-1455
pubmed: 29616422
Nat Commun. 2015 Oct 30;6:8727
pubmed: 26515465
Oncotarget. 2014 Jul 15;5(13):4651-64
pubmed: 25026291
Elife. 2018 Jun 19;7:
pubmed: 29916366
Mol Immunol. 2019 May;109:20-26
pubmed: 30851633
Oncoimmunology. 2018 Mar 15;7(6):e1433981
pubmed: 29872568
Cell. 2015 Jan 15;160(1-2):48-61
pubmed: 25594174
Int J Oncol. 2008 Mar;32(3):609-17
pubmed: 18292938
Oncologist. 2020 Jun;25(6):481-487
pubmed: 31967692
Environ Microbiol. 2009 Oct;11(10):2574-84
pubmed: 19601958
Cell Metab. 2015 Jun 2;21(6):891-7
pubmed: 25959674
J Transl Med. 2012 Oct 03;10:205
pubmed: 23034130
Oncoimmunology. 2018 Feb 16;7(5):e1424676
pubmed: 29721389
Lancet. 2003 Jun 28;361(9376):2235-42
pubmed: 12842380
PLoS One. 2011;6(5):e20447
pubmed: 21647227
Annu Rev Immunol. 2016 May 20;34:335-68
pubmed: 26907215
Eur J Immunol. 2015 Apr;45(4):999-1009
pubmed: 25545618
Nutrients. 2020 Jul 26;12(8):
pubmed: 32722632
Nature. 2015 May 7;521(7550):94-8
pubmed: 25924065
Cancer Discov. 2018 Jun;8(6):730-749
pubmed: 29510987
Int Immunol. 2013 Feb;25(2):129-37
pubmed: 23087177
BMC Cancer. 2020 Jul 22;20(1):683
pubmed: 32698790
Nat Med. 2020 Jun;26(6):919-931
pubmed: 32451498
PLoS One. 2014 Jan 29;9(1):e86702
pubmed: 24489770
Sci Rep. 2018 Mar 16;8(1):4736
pubmed: 29549283
J Clin Invest. 2013 Jul;123(7):2873-92
pubmed: 23778140
Immunol Rev. 2007 Dec;220:47-59
pubmed: 17979839
J Natl Cancer Inst. 2010 May 5;102(9):614-26
pubmed: 20407088
Nature. 2012 May 09;486(7402):222-7
pubmed: 22699611
Nature. 2014 Jan 23;505(7484):559-63
pubmed: 24336217
Nat Rev Immunol. 2017 Feb;17(2):97-111
pubmed: 27748397
J Immunother Cancer. 2020 Aug;8(2):
pubmed: 32817209
Gut. 2000 Sep;47(3):397-403
pubmed: 10940278
Exp Cell Res. 2018 Nov 1;372(1):35-42
pubmed: 30205088
Trends Cogn Sci. 2013 Feb;17(2):60-8
pubmed: 23290054
Cancer Res. 2013 Apr 1;73(7):2127-38
pubmed: 23365136
Cancer Immunol Res. 2015 Feb;3(2):103-9
pubmed: 25660553
Science. 2010 Nov 5;330(6005):831-5
pubmed: 21051639
Front Immunol. 2021 Jan 08;11:573158
pubmed: 33488574
Curr Pharm Biotechnol. 2003 Aug;4(4):260-9
pubmed: 14529428
Cancer Metastasis Rev. 2011 Mar;30(1):61-9
pubmed: 21249425
Onco Targets Ther. 2019 May 14;12:3671-3682
pubmed: 31190869
Cancer Cell. 2010 Feb 17;17(2):121-34
pubmed: 20138013
Clin Cancer Res. 2017 Jan 1;23(1):250-262
pubmed: 27354470
Annu Rev Immunol. 2013;31:51-72
pubmed: 23157435
Eur J Cancer. 2019 Dec;123:118-129
pubmed: 31678770
Science. 2017 Oct 20;358(6361):359-365
pubmed: 29051379
Front Immunol. 2016 Dec 08;7:560
pubmed: 28008330
FEMS Microbiol Ecol. 2002 Jan 1;39(1):33-9
pubmed: 19709182
Cell. 2014 Nov 6;159(4):789-99
pubmed: 25417156
Proc Natl Acad Sci U S A. 2002 Nov 26;99(24):15451-5
pubmed: 12432102
Clin Microbiol Infect. 2021 Jun;27(6):912.e7-912.e13
pubmed: 32835795
Proc Natl Acad Sci U S A. 2014 Dec 23;111(51):18321-6
pubmed: 25489084
Cell. 1990 Jun 1;61(5):759-67
pubmed: 2188735
J Clin Oncol. 2020 Jan 1;38(1):11-19
pubmed: 31725351
Science. 2001 Feb 2;291(5505):881-4
pubmed: 11157169
Nature. 2006 Apr 6;440(7085):808-12
pubmed: 16489357
Cell Host Microbe. 2016 Aug 10;20(2):215-25
pubmed: 27512904
BMC Gastroenterol. 2006 Jan 12;6:4
pubmed: 16409634
Cancer Res. 2007 Mar 1;67(5):1883-6
pubmed: 17332313
Science. 2011 Oct 7;334(6052):105-8
pubmed: 21885731
Am J Gastroenterol. 2005 Nov;100(11):2560-8
pubmed: 16279914
Oncogene. 2010 Jan 28;29(4):482-91
pubmed: 19881547
Gut Pathog. 2013 Mar 07;5(1):2
pubmed: 23497613
Mucosal Immunol. 2019 Jan;12(1):164-177
pubmed: 30279518
J Clin Oncol. 2018 Mar 10;36(8):773-779
pubmed: 29355075
Nat Genet. 2016 Nov;48(11):1413-1417
pubmed: 27694960
Sci Transl Med. 2015 Jan 21;7(271):271ps1
pubmed: 25609166
Gut. 2017 Apr;66(4):683-691
pubmed: 26818619
Front Oncol. 2020 Jul 07;10:902
pubmed: 32733788
Sci Rep. 2019 Dec 27;9(1):19997
pubmed: 31882709
Radiographics. 2019 Mar-Apr;39(2):367-387
pubmed: 30768361
Front Oncol. 2020 Apr 23;10:586
pubmed: 32391270
Oncotarget. 2017 Oct 27;8(62):105299-105311
pubmed: 29285252
J Appl Microbiol. 2003;95(3):508-20
pubmed: 12911699
N Engl J Med. 2004 Jun 3;350(23):2343-51
pubmed: 15175436
FEMS Microbiol Ecol. 2005 Oct 1;54(2):219-31
pubmed: 16332321
Ann Oncol. 2020 Jul;31(7):921-929
pubmed: 32294529
Nat Rev Microbiol. 2012 Oct;10(10):717-25
pubmed: 22941505
J Clin Oncol. 2011 Feb 20;29(6):610-8
pubmed: 21245428
Immunity. 2016 Mar 15;44(3):698-711
pubmed: 26982367
JCO Precis Oncol. 2019 Dec;3:1-5
pubmed: 35100706
Immunity. 2017 Apr 18;46(4):532-548
pubmed: 28423335
Gut Microbes. 2014;5(5):675-80
pubmed: 25483338
Eur Urol. 2020 Aug;78(2):195-206
pubmed: 32376136
Nat Rev Immunol. 2017 Dec;17(12):733-745
pubmed: 28920588
Immunity. 2018 Apr 17;48(4):812-830.e14
pubmed: 29628290
Dig Dis Sci. 2020 Sep;65(9):2595-2604
pubmed: 32140945
Sci Transl Med. 2014 Mar 19;6(228):228ra37
pubmed: 24648340
Microbiol Immunol. 2002;46(8):535-48
pubmed: 12363017
Cell. 2017 Apr 20;169(3):442-456.e18
pubmed: 28431245
Gut. 2015 Mar;64(3):428-37
pubmed: 24898815
Immunity. 2014 May 15;40(5):785-800
pubmed: 24816404
Gut. 2015 Oct;64(10):1553-61
pubmed: 25596182
Oncotarget. 2017 Nov 30;8(67):112116-112131
pubmed: 29340116
Nat Med. 2007 Sep;13(9):1050-9
pubmed: 17704786
Science. 2011 Jan 21;331(6015):337-41
pubmed: 21205640
DNA Res. 2007 Aug 31;14(4):169-81
pubmed: 17916580
Gut Pathog. 2010 Dec 09;2(1):19
pubmed: 21143915
Gastroenterology. 2010 Jun;138(6):2073-2087.e3
pubmed: 20420947
Oncoimmunology. 2015 Jun 9;5(1):e1057388
pubmed: 26942067
Proc Natl Acad Sci U S A. 2010 Aug 17;107(33):14691-6
pubmed: 20679230
J Pathol. 2014 Jan;232(2):199-209
pubmed: 24122236
JCI Insight. 2019 Aug 13;5:
pubmed: 31408436
Microb Ecol Health Dis. 2015 Feb 02;26:26050
pubmed: 25651996
PLoS One. 2012;7(6):e39743
pubmed: 22761885
Trends Cancer. 2016 Mar;2(3):121-133
pubmed: 28741532
Science. 2020 Sep 18;369(6510):1481-1489
pubmed: 32792462
Gastroenterology. 2014 May;146(6):1489-99
pubmed: 24560869
Cancer Epidemiol Biomarkers Prev. 2017 Mar;26(3):366-375
pubmed: 27811119
Gut. 2017 Sep;66(9):1709-1717
pubmed: 28663354
Science. 2018 Jan 5;359(6371):97-103
pubmed: 29097493
Science. 2019 Jun 21;364(6446):1179-1184
pubmed: 31221858
J Hematol Oncol. 2020 Jun 5;13(1):68
pubmed: 32503584
Nat Med. 2018 Nov;24(11):1649-1654
pubmed: 30297909
Appl Environ Microbiol. 2002 Jul;68(7):3401-7
pubmed: 12089021
Aging Cell. 2012 Feb;11(1):128-38
pubmed: 22044484
J Exp Med. 2006 Oct 2;203(10):2271-9
pubmed: 16982811
Immunol Rev. 2020 Jul;296(1):48-61
pubmed: 32412663
Nature. 2020 Jan;577(7791):561-565
pubmed: 31942071
Cell. 2018 Jun 28;174(1):88-101.e16
pubmed: 29909986
Nat Med. 2018 Jul;24(7):994-1004
pubmed: 29892065
Cell. 2004 Jul 23;118(2):229-41
pubmed: 15260992
Cancer Res. 2011 Feb 15;71(4):1263-71
pubmed: 21303976
Proc Natl Acad Sci U S A. 2011 Mar 15;108 Suppl 1:4578-85
pubmed: 20668239
N Engl J Med. 2017 Oct 5;377(14):1345-1356
pubmed: 28889792
Clin Gastroenterol Hepatol. 2019 Jun;17(7):1323-1331.e6
pubmed: 30056182
Immunity. 2012 Feb 24;36(2):262-75
pubmed: 22326580
Nat Cancer. 2020 Jun;1(6):620-634
pubmed: 35121975
Nat Rev Microbiol. 2017 Sep;15(9):531-543
pubmed: 28603278
JCI Insight. 2017 Jun 2;2(11):
pubmed: 28570278
EMBO J. 2009 Mar 4;28(5):578-90
pubmed: 19165151
Immunity. 2013 Oct 17;39(4):782-95
pubmed: 24138885
Nat Rev Microbiol. 2012 Jun 25;10(8):575-82
pubmed: 22728587
J Immunother Cancer. 2019 Nov 27;7(1):324
pubmed: 31775909
N Engl J Med. 2019 Nov 21;381(21):2020-2031
pubmed: 31562796
Science. 2013 Nov 22;342(6161):971-6
pubmed: 24264990
J Exp Med. 2005 Dec 19;202(12):1691-701
pubmed: 16365148
Nature. 2012 Jul 18;487(7407):330-7
pubmed: 22810696
PLoS Biol. 2016 Aug 19;14(8):e1002533
pubmed: 27541692
Science. 2018 Feb 2;359(6375):592-597
pubmed: 29420293
ISME J. 2011 Feb;5(2):220-30
pubmed: 20686513
Cell. 2017 Jul 27;170(3):548-563.e16
pubmed: 28753429
Science. 2015 Nov 27;350(6264):1079-84
pubmed: 26541610
Am J Clin Oncol. 1998 Jun;21(3):279-83
pubmed: 9626798
J Clin Oncol. 2009 Dec 10;27(35):5944-51
pubmed: 19858404
BMC Genomics. 2017 Jan 25;18(Suppl 1):932
pubmed: 28198673
Science. 2018 Jan 5;359(6371):91-97
pubmed: 29097494
Nat Med. 2016 Jun;22(6):679-84
pubmed: 27111280
Clin Transl Gastroenterol. 2016 Nov 3;7(11):e200
pubmed: 27811909
Cancer Res. 2014 Mar 1;74(5):1311-8
pubmed: 24385213
J Clin Invest. 2019 Mar 11;129(4):1699-1712
pubmed: 30855275
J Clin Oncol. 2000 Jan;18(1):136-47
pubmed: 10623704
Ann Oncol. 2016 Aug;27(8):1386-422
pubmed: 27380959
Cell Commun Signal. 2019 Jul 22;17(1):79
pubmed: 31331345
Cancer Lett. 2013 Jun 10;333(2):222-8
pubmed: 23370224
Immunity. 2020 Mar 17;52(3):557-570.e6
pubmed: 32160523
CA Cancer J Clin. 2017 Mar;67(2):93-99
pubmed: 28094848
Nature. 2011 May 12;473(7346):174-80
pubmed: 21508958
Sci Rep. 2016 Sep 28;6:33440
pubmed: 27678333
Oncol Lett. 2019 Dec;18(6):5977-5985
pubmed: 31788072
Int J Cancer. 2012 Oct 1;131(7):1499-508
pubmed: 22212899
Cell Host Microbe. 2014 Mar 12;15(3):317-28
pubmed: 24629338
Clin Ther. 2005 Jan;27(1):23-44
pubmed: 15763604
Genome Res. 2012 Feb;22(2):292-8
pubmed: 22009990
Nat Commun. 2014 Sep 03;5:4724
pubmed: 25182170
Oncologist. 2020 Jan;25(1):33-45
pubmed: 31383813
ISME J. 2010 Feb;4(2):232-41
pubmed: 19865183
J Natl Cancer Inst. 2018 Jan 1;110(1):
pubmed: 28922789
Gene Ther. 2019 Nov;26(10-11):441-454
pubmed: 30770895
Am J Respir Crit Care Med. 2014 Apr 1;189(7):832-44
pubmed: 24484236
Int Immunopharmacol. 2019 Jan;66:127-138
pubmed: 30448635
Cell Host Microbe. 2018 Feb 14;23(2):203-214.e5
pubmed: 29398651
Nat Rev Immunol. 2009 May;9(5):313-23
pubmed: 19343057
Cells. 2019 May 13;8(5):
pubmed: 31086070
J Med Microbiol. 2005 Nov;54(Pt 11):1093-1101
pubmed: 16192442
Cytokine. 2001 Aug 7;15(3):113-21
pubmed: 11554781
Sci Rep. 2015 Jun 02;5:10665
pubmed: 26035423
Cancer J. 2014 May-Jun;20(3):225-31
pubmed: 24855012
Nat Med. 2009 Sep;15(9):1016-22
pubmed: 19701202
Science. 2012 Oct 5;338(6103):120-3
pubmed: 22903521
Front Immunol. 2018 Dec 18;9:2986
pubmed: 30619341
Fam Cancer. 2016 Jul;15(3):405-12
pubmed: 26875156
J Immunol. 2013 Jul 1;191(1):217-27
pubmed: 23698748
Science. 2005 Jun 10;308(5728):1635-8
pubmed: 15831718
Cell. 2005 Jul 15;122(1):107-18
pubmed: 16009137
Cell Host Microbe. 2014 Mar 12;15(3):382-392
pubmed: 24629344
Proc Natl Acad Sci U S A. 2004 Mar 23;101(12):4250-5
pubmed: 15016918
J Immunol. 2006 Jan 15;176(2):803-10
pubmed: 16393963
Science. 2017 Sep 15;357(6356):1156-1160
pubmed: 28912244
Front Immunol. 2017 May 26;8:619
pubmed: 28603527
Nat Rev Cancer. 2017 Feb;17(2):79-92
pubmed: 28050011
Immunity. 2015 Feb 17;42(2):344-355
pubmed: 25680274
Cancer Cell. 2018 Jun 11;33(6):1017-1032.e7
pubmed: 29894689
Gut. 2017 Apr;66(4):692-704
pubmed: 26719303
Cell. 2009 Oct 30;139(3):485-98
pubmed: 19836068
Science. 2006 Jun 2;312(5778):1355-9
pubmed: 16741115
Mol Pharmacol. 1998 Nov;54(5):770-7
pubmed: 9804612
Clin Cancer Res. 2014 Feb 15;20(4):859-67
pubmed: 24334760
Sci Signal. 2020 Jul 21;13(641):
pubmed: 32694172
Gut. 2018 Nov;67(11):1984-1994
pubmed: 29437871
Appl Environ Microbiol. 2007 Nov;73(22):7435-42
pubmed: 17890331
Science. 2013 Nov 22;342(6161):967-70
pubmed: 24264989
Hum Immunol. 2018 Jun;79(6):446-452
pubmed: 29544815
Nat Biomed Eng. 2019 Sep;3(9):717-728
pubmed: 31332342
Oncoimmunology. 2017 Apr 5;6(5):e1313369
pubmed: 28638741

Auteurs

Marine Fidelle (M)

Gustave Roussy, Villejuif, France.
Institut National de la Santé Et de la Recherche Médicale (INSERM) U1015, Villejuif, France.
Equipe Labellisée-Ligue Nationale contre le Cancer, Villejuif, France.
Center of Clinical Investigations in Biotherapies of Cancer (CICBT) 1428, Villejuif, France.
Université Paris-Saclay, Gustave Roussy, Villejuif, France.

Satoru Yonekura (S)

Gustave Roussy, Villejuif, France.
Institut National de la Santé Et de la Recherche Médicale (INSERM) U1015, Villejuif, France.
Equipe Labellisée-Ligue Nationale contre le Cancer, Villejuif, France.
Université Paris-Saclay, Gustave Roussy, Villejuif, France.

Marion Picard (M)

Gustave Roussy, Villejuif, France.
Institut National de la Santé Et de la Recherche Médicale (INSERM) U1015, Villejuif, France.
Equipe Labellisée-Ligue Nationale contre le Cancer, Villejuif, France.
Unit Biology and Genetics of the Bacterial Cell Wall, Institut Pasteur, Paris, France.

Alexandria Cogdill (A)

Department of Immunology, University of Texas, MD Anderson Cancer Center, Houston, TX, United States.
Department of Genomic Medicine, University of Texas, MD Anderson Cancer Center, Houston, TX, United States.

Antoine Hollebecque (A)

Gustave Roussy, Villejuif, France.
Department of Medical Oncology, Gustave Roussy, Villejuif, France.

Maria Paula Roberti (MP)

Gustave Roussy, Villejuif, France.
Institut National de la Santé Et de la Recherche Médicale (INSERM) U1015, Villejuif, France.
Equipe Labellisée-Ligue Nationale contre le Cancer, Villejuif, France.

Laurence Zitvogel (L)

Gustave Roussy, Villejuif, France.
Institut National de la Santé Et de la Recherche Médicale (INSERM) U1015, Villejuif, France.
Equipe Labellisée-Ligue Nationale contre le Cancer, Villejuif, France.
Center of Clinical Investigations in Biotherapies of Cancer (CICBT) 1428, Villejuif, France.
Université Paris-Saclay, Gustave Roussy, Villejuif, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH